FDA Adverse Event Injury Summary report: N

TELIGEN

MDR report key: 1952196 · Received January 7, 2011

Report

Report Number
2124215-2010-23444
Event Type
Injury
Date Received
January 7, 2011
Date of Event
December 1, 2010
Report Date
December 1, 2010
Manufacturer
GUIDANT CRM CLONMEL IRELAND
Product Code
LWS
PMA / PMN Number
P960040
Adverse Event
Yes
Product Problem
Yes
Report Source
Manufacturer report
Reporter Occupation
MEDICAL EQUIPMENT COMPANY TECHNICIAN/REPRESENTATIVE

Narratives

Additional Manufacturer Narrative · 1

SHOULD ADDITIONAL INFORMATION BECOME AVAILABLE THIS EVENT WILL BE UPDATED AND RESUBMITTED.

Description of Event or Problem · 1

BOSTON SCIENTIFIC RECEIVED INFORMATION THAT THIS DEVICE WAS IMPLANTED IN (B)(6) 2010. THE ASSOCIATED COMPETITOR RIGHT VENTRICULAR LEAD DISLODGED LEADING TO MULTIPLE INAPPROPRIATE SHOCKS AND SYNCOPE. THE DISLODGEMENT POSITIONED THE LEAD AT THE VALVE, IRRITATING THE HEART AND DOUBLE COUNTING T AND R WAVES. THIS PATIENT IS PACEMAKER DEPENDENT AND PACING INHIBITION WAS OBSERVED DUE TO TORSADES DE POINTES. THE COMPETITOR LEAD WAS REPOSITIONED. UPON REPOSITIONING AND REPROGRAMMING THE DEVICE LONGEVITY IMPROVED SUBSTANTIALLY. CURRENTLY, THIS DEVICE REMAINS IMPLANTED AND IN SERVICE. NO ADDITIONAL PATIENT EFFECTS REPORTED.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 TELIGEN IMPLANTABLE CARDIOVERTER DEFIBRILLATOR LWS GUIDANT CRM CLONMEL IRELAND E110

Patients

Seq Age Sex Outcome Treatment
1 62 YR Life Threatening| R 6937| T125| 6943| 1821| E110| 4269| 1861| 5076| 7120